Can Hexarelin improve cardiac function in age-related heart failure? — RetatrutideCompare

Peptide Longevity Q&A ·

Hexarelin has been shown to improve cardiac function in rats with heart failure by enhancing phosphatase and tensin homologue (PTEN) expression and inhibiting the Akt/mTOR signaling pathway, which may have implications for age-related heart conditions.

What the research shows

The study investigated the effects of hexarelin, a synthetic growth hormone-releasing peptide, on heart failure induced by coronary artery ligation (CAL) in rats. The research involved four groups: a control group, a sham group, a hexarelin treatment group, and a heart failure group. The treatment group received subcutaneous injections of hexarelin (100 µg/kg) twice daily for 30 days, while the other groups received saline. The study measured left ventricular (LV) function, oxidative stress, apoptosis, and various molecular and structural cardiac changes.

Why it matters for longevity

Heart failure is a significant health concern, particularly in aging populations. The findings suggest that hexarelin may have cardioprotective effects that could be beneficial in managing age-related heart conditions. By improving LV function and reducing oxidative stress, hexarelin may contribute to enhanced cardiac health and longevity, potentially mitigating the impacts of aging on heart function.

Key findings at a glance

  • Hexarelin improved left ventricular function in rats with heart failure.
  • The peptide upregulated PTEN expression, which plays a role in cellular signaling.
  • Hexarelin inhibited the phosphorylation of Akt and mTOR, key pathways in cellular growth and metabolism.
  • Oxidative stress and myocardial remodeling were significantly reduced in the treatment group.
  • The study highlights the potential of hexarelin in addressing cardiac dysfunction related to aging.

How Hexarelin works (background)

Hexarelin functions by modulating various signaling pathways involved in cardiac health. It enhances the expression of PTEN, a phosphatase that regulates cell growth and survival. By inhibiting the Akt/mTOR pathway, hexarelin reduces excessive cellular proliferation and promotes healthier cardiac remodeling. This mechanism is crucial in preventing the progression of heart failure, particularly in aging models where oxidative stress and myocardial damage are prevalent.

Safety, caveats, and what we don't yet know

While the study demonstrates the potential benefits of hexarelin in a preclinical model, further research is needed to fully understand its effects in humans. The study was conducted on rats, and results may not directly translate to human physiology. Additionally, the long-term safety and efficacy of hexarelin in various populations, particularly older adults with existing heart conditions, require further investigation. There are also no established guidelines for hexarelin use in clinical settings, making it essential to approach its application cautiously.

Bottom line

Hexarelin shows promise in improving cardiac function and reducing oxidative stress in models of heart failure, which may have implications for aging-related heart conditions.

Related questions

Does Hexarelin have effects on muscle health in aging?

Research indicates that peptides like hexarelin may influence muscle health by promoting growth hormone release, which could help mitigate age-related muscle loss. However, specific studies focusing on muscle health and hexarelin are still needed.

Can Hexarelin support recovery from cardiac events?

Hexarelin has shown potential in enhancing recovery from cardiac events in preclinical models by improving cardiac function and reducing oxidative stress. Further research is necessary to confirm these effects in human populations.

What are the potential benefits of Hexarelin for metabolic health?

While hexarelin primarily focuses on cardiac health, its influence on growth hormone pathways may also extend to metabolic health. Research is ongoing to explore its effects on insulin sensitivity and metabolic aging.

Source: PubMed · Turk J Med Sci · published 2019-06-18.